Casdin Capital, LLC
Director at GeneDx Holdings; Director at Standard BioTools; 10% owner at MaxCyte.
- Rank
- 498th of 813
- Companies held
- 3
- Largest holding
- WGS, 90.4% of total
- Latest SEC filing
- Feb 28, 2025
- Listed but not counted
- $98.9M
What the $175M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| GeneDx Holdings WGS Class A Common Stock | Directly | 3,093,509 | $49.24 | $152M | 87.2% | Form 4, Jun 4, 2024 |
| MaxCyte MXCT Common Stock, par value $0.01 per share | Directly | 10,000,000 | $1.28 | $12.8M | 7.3% | Form 4, Oct 3, 2022 |
| GeneDx Holdings WGS Class A Common Stock | Indirectly (see filing footnote) Reported jointly by 3 insiders; split evenly | 111,048 | $49.24 | $5.5M | 3.1% | Form 4, Jun 3, 2024 |
| Standard BioTools LAB Common Stock | Indirectly (see filing footnote) | 3,774,000 | $0.61 | $2.3M | 1.3% | Form 4, Jun 18, 2024 |
| Standard BioTools LAB Common Stock | Directly | 2,806,470 | $0.61 | $1.7M | 1.0% | Form 4, Feb 28, 2025 |
Share counts are the amounts Casdin Capital, LLC reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Casdin Capital, LLC's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Standard BioTools LAB Common Stock | Through Casdin Partners Master Fund, L.P. Held by a company or fund the insider manages | 59,391,780 | $0.61 | $36.5M | — | Form 4, Feb 28, 2025 |
| Standard BioTools LAB Common Stock | Indirectly (see filing footnote) Held by a company or fund the insider manages | 46,730,821 | $0.61 | $28.7M | — | Form 4, Jun 18, 2024 |
| GeneDx Holdings WGS Class A Common Stock | Through CMLS Holdings LLC Held by a company or fund the insider manages | 432,902 | $49.24 | $21.3M | — | Form 4, Jun 3, 2024 |
| Standard BioTools LAB Common Stock | Through Casdin Private Growth Equity Fund II, L.P. Held by a company or fund the insider manages | 13,939,637 | $0.61 | $8.6M | — | Form 4, Feb 28, 2025 |
| Tenaya Therapeutics TNYA Common Stock | Through Casdin Capital, LLC Held by a company or fund the insider manages | 6,078,860 | $0.30 | $1.8M | — | Form 4, Nov 17, 2022 |
| Standard BioTools LAB Common Stock | Through Casdin Private Growth Equity Fund, L.P. Held by a company or fund the insider manages | 2,744,219 | $0.61 | $1.7M | — | Form 4, Feb 28, 2025 |
| Standard BioTools LAB Common Stock | Through Casdin Capital, LLC Held by a company or fund the insider manages | 545,000 | $0.61 | $335K | — | Form 4, Jun 18, 2024 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 495 | EnerVest Management GP, L.C. Director, Magnolia Oil & Gas | $177M |
| 496 | Gmt Capital Corp 10% owner, Cracker Barrel Old Country Store | $176M |
| 497 | InnoCare Pharma Inc. 10% owner, Zenas BioPharma | $175M |
| 498 | Casdin Capital, LLC Director, GeneDx Holdings | $175M |
| 499 | Ldb C LLC Insider, Apollo Global Management | $174M |
| 500 | Ldb 2025 LLC Insider, Apollo Global Management | $174M |
| 501 | Two Sigma Investments, LP 10% owner, Hamilton Insurance Group | $171M |
Other GeneDx Holdings insiders
All WGS insiders- Icahn School Of Medicine At Mount Sinai$134M10% owner. #1200 overall
- Jason Ryan$12.8MDirector. #7283 overall
- Katherine Stueland$5.7MCHIEF EXECUTIVE OFFICER. #13244 overall
- Emily M. Leproust$1.2MDirector. #1869 overall
Questions
How much stock does Casdin Capital, LLC own?
Casdin Capital, LLC holds $174,632,795 in listed stock based on SEC filings and current prices, mostly GeneDx Holdings (WGS). That ranks 498th on the Stock Rich List.
Is this Casdin Capital, LLC's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
Files jointly with SEC filer 1534264.